US & Canada, May 23, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the aortic stent graft market is witnessing significant growth owing to the rising ...

NEW YORK, Aug. 14, 2019 /PRNewswire/ -- The aortic stent graft market is expected to reach over $3.7 billion by 2024, growing at an impressive CAGR of around 6% during 2018–2024.

An aortic stent graft, also known as an endovascular stent graft (EVAR), is a minimally invasive solution for repairing aneurysms. Unlike traditional open surgery, which involves a large incision and ...

Additionally, in a prespecified analysis of approximately 2,700 patients that only included aortic stent grafts placed between February 22, 2016, and December 31, 2017—the time period when the AFX2 ...

The Anaconda stent graft, manufactured by Vascutek, is delivered by a 20-Fr. to 22-Fr. system, with the largest proximal graft size at 34 mm and the largest iliac graft at 23 mm.

Our aim was to report single-center results of emergency endovascular treatment for thoracic aortic disease. From March 1998 to January 2006, 30 acute thoracic EVAR procedures were carried out in ...

Methods For the phase 2 investigational device exemption trial, researchers led by Christopher J. Kwolek, MD, of Massachusetts General Hospital (Boston, MA), enrolled 195 AAA patients with or without ...

The U.S. Food and Drug Administration (FDA) approved the Endurant AAA Stent Graft System in December 2010. Since then, the device has been used to treat more than 6,000 patients in the United States.

2.1 Indications 2.1.1 Stent–graft placement is used to treat aneurysms of the abdominal aorta. Weakening of the wall of the aorta can lead to widening of the vessel, or aneurysm. Aneurysms may rupture ...

1. Market Growth: The aortic stent graft market value is expected to reach US$ 4.03 billion by 2031 from US$ 2.62 billion in 2024; the market is anticipated to register a CAGR of 6.5% during 2025 ...